International Flavors&Fragranc Stock Price, News & Analysis

On April 6, 2023, IFF announced a study in collaboration with IRCAM Amplify, exploring the strong connections between sound, smell, emotion, and consumer behavior. The research reveals that sound can elevate purchase intent for scents by 58% in e-commerce contexts, enhancing emotional ties to fragrances. This innovation is positioned to transform online shopping by enabling brands to market new scents digitally, thereby driving business growth. IFF, a leader in scent creation, employs extensive consumer data and AI tools, which, combined with IRCAM's sound design expertise, opens new avenues for scent marketing in various product categories, including home and beauty. The study underscores the potential of a multi-sensory experience to improve user experience and brand engagement.

IFF has successfully achieved a significant milestone in the dietary supplement industry by encapsulating high viscosity liquid and semi-liquid ingredients using its patented SeaGel^® technology. This breakthrough allows for the development of plant-based softgels that rival traditional gelatin products. Notably, IFF has partnered with AQUANOVA AG to encapsulate NovaSOL^® Curcumin in a vegan format, addressing the growing consumer demand for plant-based alternatives. This advancement enhances encapsulation efficiency and is expected to cater to the increasing market for plant-based supplements.

Danisco Animal Nutrition & Health, part of IFF, launched Axtra® PRIME, a new enzyme blend for piglet production aimed at enhancing nutrient digestion and gut health. Available in the U.S., this solution addresses challenges like weaning stress and diet variability, which can negatively impact piglet performance. The blend contains multiple enzymes, including xylanase and protease, and has shown promising results in improving growth rates and overall profitability for producers. IFF continues its commitment to innovative solutions in animal nutrition to support better health outcomes and operational efficiency.

IFF has achieved a breakthrough in encapsulation technology, successfully encapsulating liquid curcumin using its patented SeaGel® in vegan softgel formats. This marks the industry’s first successful application of high viscosity liquid ingredients in plant-based supplements. This innovation allows manufacturers to produce high-quality soft-shell capsules that meet the growing consumer demand for plant-based dietary options.

The collaboration with AQUANOVA AG highlights IFF's commitment to address the challenges faced in developing softgel technology for dietary supplements, expanding the efficacy and application scope of natural ingredients.

International Flavors & Fragrances (IFF) announced that TRC Capital Investment Corporation has made an unsolicited mini-tender offer to purchase up to 1,500,000 shares at $81.60 per share, a 1.4% discount from the March 17 closing price of $82.76. IFF advises shareholders not to tender their shares, as the offer price is below market value and contingent upon several conditions. The offer expires on April 4, 2023, unless extended. IFF does not endorse this bid and highlights that such offers lack the protections outlined by SEC rules. Shareholders are encouraged to consult market prices and seek advice from financial advisors.

Danisco Animal Nutrition & Health, a unit of IFF, launched Axtra® PRIME, an optimized enzyme blend for piglet production, on March 14, 2023, in the U.S.. This product aims to enhance nutrient digestion, improving gut health and piglet performance during critical early growth stages. The blend includes xylanase, beta-glucanase, alpha-amylase, and protease enzymes, tailored to address challenges like weaning stress and dietary variability that can impact feed efficiency. Research demonstrates significant benefits of this enzyme formulation on piglet growth and producer profitability.

IFF (NYSE: IFF) has declared a quarterly cash dividend of $0.81 per share, payable on April 6, 2023, to shareholders of record as of March 24, 2023. This decision reflects the company's commitment to returning value to its shareholders while maintaining financial stability. IFF continues to lead in the food, beverage, scent, health, and biosciences sectors, merging science and creativity to deliver essential solutions. Stay informed about IFF's initiatives and updates by visiting iff.com.

International Flavors & Fragrances (NYSE: IFF) is evolving its Board of Directors to enhance its strategic transformation and financial vision. Effective March 10, 2023, Kevin O’Byrne, CFO of J Sainsbury Plc, will join the Board, bringing extensive experience in consumer retail. He will serve on the Audit, Innovation, and Transaction Committees. Meanwhile, Ed Breen, Matthias Heinzel, and Stephen Williamson will retire from the Board, with Williamson's departure also effective March 10. The Chairman expressed gratitude for their contributions, emphasizing the company’s commitment to long-term growth and innovation under new leadership.

IFF (NYSE: IFF) has agreed to sell its Flavor Specialty Ingredients (FSI) business to UK-based private equity firm Exponent for $220 million. The sale aims to strengthen IFF's financial profile by reducing outstanding debt and allowing the company to concentrate on core operations. FSI is a leading manufacturer of aroma chemicals for the flavor market, generating over $100 million in revenue in the past year. The transaction is expected to close by the end of Q3 2023, pending customary conditions.